Albarico, Ermie R.

HRN: 21-47-53  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CEFTRIAXONE 1G (VIAL)
06/20/2022
06/26/2022
IV
2 Grams
OD
Empiric
Waiting Final Action 
11/05/2022
MUPIROCIN 2%, 15G (TUBE)
11/05/2022
11/12/2022
TOPICAL
2%
BID
Wound Left Ankle
Waiting Final Action 
11/06/2022
CEFUROXIME 1.5GM (VIAL)
11/06/2022
11/12/2022
IV
1.5g
Q8h
UTI
06/29/2023
AZITHROMYCIN 500MG TABLET (TAB)
06/29/2023
07/05/2023
ORAL
500mg/tab
OD
CAP-MR
Waiting Final Action 
06/29/2023
CEFTRIAXONE 1G (VIAL)
06/29/2023
07/05/2023
IV
2grams
OD
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: